A Phase 1, Open-label, Safety and Immunogenicity Study of an Oral Multi-dose Administration Regimen With an Adenoviral-vector Based Tablet Norovirus Vaccine (VXA-G1.1-NN) Administered to Healthy Adult Volunteers

Clinical trial NCT05213728 · COMPLETED

Trial details

NCT number: NCT05213728
Sponsor: Vaxart
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Norovirus Infections

Start date: 2022-01-24
Primary completion: 2022-02-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.